These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24129630)

  • 1. Low-virulence phylogenetic background of CTX-M-producing Escherichia coli isolated from extraintestinal infections.
    Paiva AL; Lincopan N; Silva KC; Neves PR; Moreno AM; McCulloch JA; Astolfi-Ferreira CS; Ferreira AJ
    J Infect Dev Ctries; 2013 Oct; 7(10):756-60. PubMed ID: 24129630
    [No Abstract]   [Full Text] [Related]  

  • 2. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
    Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP
    J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTX-M beta-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors.
    Lavigne JP; Marchandin H; Delmas J; Moreau J; Bouziges N; Lecaillon E; Cavalie L; Jean-Pierre H; Bonnet R; Sotto A
    J Clin Microbiol; 2007 Feb; 45(2):620-6. PubMed ID: 17108071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain).
    Coelho A; Mora A; Mamani R; López C; González-López JJ; Larrosa MN; Quintero-Zarate JN; Dahbi G; Herrera A; Blanco JE; Blanco M; Alonso MP; Prats G; Blanco J
    J Antimicrob Chemother; 2011 Mar; 66(3):517-26. PubMed ID: 21177675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiresistant extended-spectrum β-lactamase producing Escherichia coli in human urine samples in Portugal.
    Pacheco R; Correia S; Monteiro R; Gonçalves A; Radhouani H; Ramos S; Carvalho E; Carvalho J; Igrejas G; Poeta P
    J Microbiol Immunol Infect; 2013 Oct; 46(5):399-404. PubMed ID: 22727541
    [No Abstract]   [Full Text] [Related]  

  • 8. Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases.
    Dahbi G; Mora A; López C; Alonso MP; Mamani R; Marzoa J; Coira A; García-Garrote F; Pita JM; Velasco D; Herrera A; Viso S; Blanco JE; Blanco M; Blanco J
    Int J Antimicrob Agents; 2013 Oct; 42(4):347-51. PubMed ID: 23992646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain.
    Mora A; Blanco M; López C; Mamani R; Blanco JE; Alonso MP; García-Garrote F; Dahbi G; Herrera A; Fernández A; Fernández B; Agulla A; Bou G; Blanco J
    Int J Antimicrob Agents; 2011 Jan; 37(1):16-21. PubMed ID: 21075606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of CTX-M-14- and CTX-M-15-producing Escherichia coli of porcine origin.
    Hammerum AM; Jakobsen L; Olsen SS; Agersø Y
    J Antimicrob Chemother; 2012 Aug; 67(8):2047-9. PubMed ID: 22523317
    [No Abstract]   [Full Text] [Related]  

  • 11. CTX-M-1-related extended-spectrum beta-lactamases producing Escherichia coli: so far a sporadic event in Western Austria.
    Prelog M; Fille M; Prodinger W; Grif K; Brunner A; Würzner R; Zimmerhackl LB
    Infection; 2008 Aug; 36(4):362-7. PubMed ID: 18574554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms.
    Van der Bij AK; Peirano G; Pitondo-Silva A; Pitout JD
    Diagn Microbiol Infect Dis; 2012 Apr; 72(4):297-302. PubMed ID: 22300954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa.
    Peirano G; van Greune CH; Pitout JD
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):449-53. PubMed ID: 21396544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.
    Blanco J; Mora A; Mamani R; López C; Blanco M; Dahbi G; Herrera A; Blanco JE; Alonso MP; García-Garrote F; Chaves F; Orellana MÁ; Martínez-Martínez L; Calvo J; Prats G; Larrosa MN; González-López JJ; López-Cerero L; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2011 Sep; 66(9):2011-21. PubMed ID: 21669946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of the IMP-8 metallo-β-lactamase in the Escherichia coli ST131 clone in Taiwan.
    Yan JJ; Tsai LH; Wu JJ
    Int J Antimicrob Agents; 2012 Sep; 40(3):281-2. PubMed ID: 22789726
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand.
    Heffernan HM; Woodhouse RE; Pope CE; Blackmore TK
    Int J Antimicrob Agents; 2009 Dec; 34(6):544-9. PubMed ID: 19748232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and characterisation of CTX-M β-lactamases amongst Escherichia coli isolates from healthy food animals in China.
    Zheng H; Zeng Z; Chen S; Liu Y; Yao Q; Deng Y; Chen X; Lv L; Zhuo C; Chen Z; Liu JH
    Int J Antimicrob Agents; 2012 Apr; 39(4):305-10. PubMed ID: 22325120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M beta-lactamases.
    Lavigne JP; Blanc-Potard AB; Bourg G; Moreau J; Chanal C; Bouziges N; O'callaghan D; Sotto A
    Clin Microbiol Infect; 2006 Dec; 12(12):1199-206. PubMed ID: 17121626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTX-M-32 beta-lactamase-producing uropathogenic Escherichia coli isolated in Latin America.
    Araque M; Millán B; Mendoza E; Salas M
    J Infect Dev Ctries; 2013 May; 7(5):432-5. PubMed ID: 23669435
    [No Abstract]   [Full Text] [Related]  

  • 20. Nosocomial transmission of NDM-1-producing Escherichia coli ST101 in a Korean hospital.
    Yoo JS; Kim HM; Koo HS; Yang JW; Yoo JI; Kim HS; Park HK; Lee YS
    J Antimicrob Chemother; 2013 Sep; 68(9):2170-2. PubMed ID: 23696618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.